Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Julide T. Celebi"'
Autor:
Michael R. Moore, Isabel D. Friesner, Emanuelle M. Rizk, Benjamin T. Fullerton, Manas Mondal, Megan H. Trager, Karen Mendelson, Ijeuru Chikeka, Tahsin Kurc, Rajarsi Gupta, Bethany R. Rohr, Eric J. Robinson, Balazs Acs, Rui Chang, Harriet Kluger, Bret Taback, Larisa J. Geskin, Basil Horst, Kevin Gardner, George Niedt, Julide T. Celebi, Robyn D. Gartrell-Corrado, Jane Messina, Tammie Ferringer, David L. Rimm, Joel Saltz, Jing Wang, Rami Vanguri, Yvonne M. Saenger
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Accurate prognostic biomarkers in early-stage melanoma are urgently needed to stratify patients for clinical trials of adjuvant therapy. We applied a previously developed open source deep learning algorithm to detect tumor-infiltrating lymph
Externí odkaz:
https://doaj.org/article/8d415bf272d94264979172564903d21c
Autor:
Mohammed Kashani-Sabet, Sancy A. Leachman, Jennifer A. Stein, Jack L. Arbiser, Elizabeth G. Berry, Julide T. Celebi, Clara Curiel-Lewandrowski, Laura K. Ferris, Jane M. Grant-Kels, Douglas Grossman, Rajan P. Kulkarni, Michael A. Marchetti, Kelly C. Nelson, David Polsky, Elizabeth V. Seiverling, Susan M. Swetter, Hensin Tsao, Alexandra Verdieck-Devlaeminck, Maria L. Wei, Anna Bar, Edmund K. Bartlett, Jean L. Bolognia, Tawnya L. Bowles, Kelly B. Cha, Emily Y. Chu, Rebecca I. Hartman, Elena B. Hawryluk, Risa M. Jampel, Lilit Karapetyan, Meenal Kheterpal, David H. Lawson, Philip D. Leming, Tracey N. Liebman, Michael E. Ming, Debjani Sahni, Stephanie A. Savory, Saba S. Shaikh, Arthur J. Sober, Vernon K. Sondak, Natalie Spaccarelli, Richard P. Usatine, Suraj Venna, John M. Kirkwood
Publikováno v:
JAMA Dermatology. 159:545
ImportanceTherapy for advanced melanoma has transformed during the past decade, but early detection and prognostic assessment of cutaneous melanoma (CM) remain paramount goals. Best practices for screening and use of pigmented lesion evaluation tools
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3060e1f164a575753c1179840b18f06
https://doi.org/10.1001/jamadermatol.2023.0127
https://doi.org/10.1001/jamadermatol.2023.0127
Autor:
Robyn D. Gartrell-Corrado, George W. Niedt, Isabel D. Friesner, Yvonne M. Saenger, Larisa J. Geskin, Karen Mendelson, Rui Chang, Michael Moore, Bethany R. Rohr, Kevin Gardner, Jing Wang, David L. Rimm, Jane L. Messina, Benjamin T. Fullerton, Eric J. Robinson, Basil A. Horst, Tammie Ferringer, Emanuelle M. Rizk, Bret Taback, Tahsin Kurc, Manas Mondal, Rajarsi Gupta, Megan H. Trager, Ijeuru Chikeka, Rami Vanguri, Balazs Acs, Harriet M. Kluger, Julide T. Celebi, Joel H. Saltz
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Accurate prognostic biomarkers in early-stage melanoma are urgently needed to stratify patients for clinical trials of adjuvant therapy. We applied a previously developed open source deep learning algorithm to detect tumor-infiltrating lymphocytes (T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e3db62167420fdb8347527ddff26315
http://europepmc.org/articles/PMC7854647
http://europepmc.org/articles/PMC7854647
Autor:
Benjamin Greenbaum, Brateil Badal, Li-Wei Chang, Julide T. Celebi, Alexander Solovyov, Ching-Jung Lu
Publikováno v:
Melanoma research. 30(6)
Mounting evidence supports a role for dysregulated long non-coding RNAs (lncRNA) in the development of many cancers. A recently discovered function of lncRNAs is to act as microRNA (miR) decoys or competing endogenous RNAs, which sequester specific m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f58c5b62936dccf4be2330cd268fdad6
https://pubmed.ncbi.nlm.nih.gov/32976222
https://pubmed.ncbi.nlm.nih.gov/32976222
Autor:
Yvonne M. Saenger, Tammy Ferringer, Ijeuru Chikeka, Tahsin Kurc, Basil A. Horst, Jing Wang, Kevin Gardner, Eric Robinson, Megan H. Trager, Bethany R. Rohr, Emanuelle M. Rizk, George W. Niedt, Isabel D. Friesner, Jane L. Messina, Larisa J. Geskin, Rami Vanguri, Julide T. Celebi, Michael Moore, Joel H. Saltz, Jeani Rich
Publikováno v:
Journal of Clinical Oncology. 38:10076-10076
10076 Background: Patients diagnosed with early stage melanoma are at risk of recurrence and death. Adjuvant therapy decreases risk but incurs toxicity and expense. While tumor-infiltrating lymphocytes (TILs) improve prognosis, studies have shown con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80ee58c6a1737cf55de03ca2498962fa
https://doi.org/10.1200/jco.2020.38.15_suppl.10076
https://doi.org/10.1200/jco.2020.38.15_suppl.10076
Autor:
Kevin J. Emmett, Raul Rabadan, Rachel D. Melamed, Geena Susan Rajan, Georg Brunner, Robert G. Phelps, David N. Silvers, Julide T. Celebi, Iraz T. Aydin
Publikováno v:
The Journal of investigative dermatology. 137(4)
A well-defined risk factor and precursor for cutaneous melanoma is the dysplastic nevus. These benign tumors represent clonal hyperproliferation of melanocytes that are in a senescent-like state, but with occasional malignant transformation events. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d129ae43f9713611b52d49d9e32f85e9
https://pubmed.ncbi.nlm.nih.gov/27890785
https://pubmed.ncbi.nlm.nih.gov/27890785
Autor:
Thomas Trimarchi, Farbod Darvishian, Kamala Bhatt, Emily I. Chen, Aristotelis Tsirigos, Kevin P. Lui, Eva Hernando, Judy Zhong, Charalampos Lazaris, Iannis Aifantis, Beatriz Aranda-Orgilles, Nikos Kourtis, Christine Salvaggio, Julide T. Celebi, Rana S. Moubarak, Iraz T. Aydin, Iman Osman
Publikováno v:
Nature cell biology
Heat-shock factor 1 (HSF1) orchestrates the heat-shock response in eukaryotes. Although this pathway has evolved to help cells adapt in the presence of challenging conditions, it is co-opted in cancer to support malignancy. However, the mechani
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c85f05fb5f37496b08e2cc5cbd4c8c13
https://pubmed.ncbi.nlm.nih.gov/25720964
https://pubmed.ncbi.nlm.nih.gov/25720964
Autor:
Raul Rabadan, Rachel D. Melamed, Carlos Cordon-Cardo, Sarah J. Adams, Julide T. Celebi, Iman Osman, Diana Bryk, Ahu Demir, Iraz T. Aydin, Mireia Castillo-Martin, Georg Brunner
Publikováno v:
JNCI: Journal of the National Cancer Institute. 106
Melanoma is a heterogeneous tumor with subgroups requiring distinct therapeutic strategies. Genetic dissection of melanoma subgroups and identification of therapeutic agents are of great interest in the field. These efforts will ultimately lead to tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7bda79c5f85512d33c1c27aec05c99f
https://doi.org/10.1093/jnci/dju107
https://doi.org/10.1093/jnci/dju107
Autor:
Julide T. Celebi, Jane L. Messina
Publikováno v:
Melanoma: Translational Research and Emerging Therapies ISBN: 1420020323
Melanoma: Translational Research and Emerging Therapies
Melanoma: Translational Research and Emerging Therapies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b87ddea13c3392799727203a07823e64
https://doi.org/10.3109/9781420020328.003
https://doi.org/10.3109/9781420020328.003
